Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stroncek

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
British Journal of Haematology|March 18, 2026
A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndromeJorge N Ruiz Lopez, Lipei Shao, Debbie Jiang, et al.
Journal of Translational Medicine|March 16, 2019
Production of a cellular product consisting of monocytes stimulated with Sylatron<sup>®</sup> (Peginterferon alfa-2b) and Actimmune<sup>®</sup> (Interferon gamma-1b) for human useDaniel S Green, Ana T Nunes, Kevin W Tosh, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Nature Medicine|April 16, 2020
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.
Nature Medicine|January 22, 2020
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.
Scientific Reports|April 28, 2017
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple CentersShutong Liu, Luis F de Castro, Ping Jin, et al.
Blood Advances|July 19, 2024
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron B Boothby, Matthew K Tanner, Abdullah Alswied, et al.
Journal of Translational Medicine|April 24, 2024
Deciphering the importance of culture pH on CD22 CAR T-cells characteristicsMichaela Prochazkova, Alexandra Dreyzin, Lipei Shao, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
British Journal of Haematology|March 18, 2026
A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndromeJorge N Ruiz Lopez, Lipei Shao, Debbie Jiang, et al.
Journal of Translational Medicine|March 16, 2019
Production of a cellular product consisting of monocytes stimulated with Sylatron<sup>®</sup> (Peginterferon alfa-2b) and Actimmune<sup>®</sup> (Interferon gamma-1b) for human useDaniel S Green, Ana T Nunes, Kevin W Tosh, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Nature Medicine|April 16, 2020
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.
Nature Medicine|January 22, 2020
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.
Scientific Reports|April 28, 2017
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple CentersShutong Liu, Luis F de Castro, Ping Jin, et al.
Blood Advances|July 19, 2024
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron B Boothby, Matthew K Tanner, Abdullah Alswied, et al.
Journal of Translational Medicine|April 24, 2024
Deciphering the importance of culture pH on CD22 CAR T-cells characteristicsMichaela Prochazkova, Alexandra Dreyzin, Lipei Shao, et al.
Pageof 22